8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2015 / Narrative review
Approximately 90% of the US population fails to consume recommended fiber levels (25 g/d for women, 38 g/d for men), averaging only 15 g/d. Fiber supplements cannot be assumed to provide the same health benefits as intact dietary fiber from whole foods, as only a minority possess the physical characteristics that drive clinical efficacy. This review focuses on four primary fiber characteristics driving efficacy—solubility, degree/rate of fermentation, viscosity, and gel formation—as well as gel-dependent small-bowel mechanisms that influence outcomes such as cholesterol lowering and glycemic control.
McRorie JW Nutr Today, 2015. PMID 25972618
2015 / Review
This narrative review examines the role of diet in the prevention and complementary clinical management of atherosclerosis. It discusses evidence and mechanisms for specific nutrients and foods, including fiber, plant sterols/stanols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy. It also highlights that intestinal microbiota dysbiosis associated with certain animal food sources can generate metabolites involved in atherosclerosis development.
Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Arch Med Res, 2015. PMID 26031780
2015 / Narrative review
This review summarizes findings on cocoa's effects on blood pressure and cardiovascular health, focusing on putative mechanisms. Flavanols in cocoa are reported to exert favorable effects on endothelium-derived vasodilation by stimulating nitric oxide-synthase, increasing l-arginine availability, and decreasing NO degradation. Cocoa is also associated with reduced platelet aggregation, decreased lipid oxidation, improved insulin resistance, and blood pressure reductions. The authors note that long-term trials are still needed to determine if daily cocoa reduces blood pressure chronically and improves cardiovascular clinical outcomes.
Ferri C, Desideri G, Ferri L, et al. J Agric Food Chem, 2015. PMID 26125676
2015 / Systematic review
A systematic review identified three randomized controlled clinical trials evaluating therapeutic fasting regimens on surrogate outcomes in humans, finding improvements in weight and other risk-related outcomes. In addition, two observational studies were identified in which fasting was associated with a lower prevalence of coronary artery disease or diabetes diagnosis. No randomized controlled trials of fasting for clinical outcomes were identified, and researchers concluded that substantial further human research is needed.
Horne BD, Muhlestein JB, Anderson JL Am J Clin Nutr, 2015. PMID 26135345
2015 / Narrative review
This review evaluates the benefits and risks of calcium supplementation in osteoporosis prevention. Most studies show little evidence linking calcium intake to bone density or bone loss, with re-analysis of the Auckland Calcium Study placebo group showing no relationship over 5 years across intakes of <400 to >1500 mg/day. Across meta-analyses, total fracture reductions range from 0-10% with no evidence for hip fracture prevention outside severe vitamin D deficiency, while five recent large studies failed to show fracture prevention in primary analyses. Conversely, supplements are associated with increased gastrointestinal side effects, a 17% increase in renal calculi, and a 20-40% increase in myocardial infarction risk.
Reid IR, Bristow SM, Bolland MJ J Intern Med, 2015. PMID 26174589
2015 / Narrative review
This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.
Moraes C, Fouque D, Amaral AC, et al. J Ren Nutr, 2015. PMID 26235933
2015 / Narrative review and metagenomic database analysis
The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.
Shows an association, not proof of cause and effect.
Falony G, Vieira-Silva S, Raes J Annu Rev Microbiol, 2015. PMID 26274026
2015 / Narrative review
This review discusses the physiological functions and potential therapeutic role of the zero-calorie functional sweetener D-allulose in managing obesity and type 2 diabetes mellitus. Human trials cited in the review demonstrated that D-allulose attenuates postprandial glucose levels in healthy subjects and in individuals with borderline diabetes. In cell culture and animal models, D-allulose demonstrated anti-hyperlipidemic, anti-hyperglycemic, and anti-inflammatory properties, with rapid elimination in rat urine within 24 hours.
Hossain A, Yamaguchi F, Matsuo T, et al. Pharmacol Ther, 2015. PMID 26297965
2015 / Review
This review evaluated studies on intermittent fasting protocols, including alternate-day fasting, whole-day fasting, and time-restricted feeding. Alternate-day fasting trials (3 to 12 weeks) were reported to reduce body weight (≈3%-7%), body fat (≈3-5.5 kg), total cholesterol (≈10%-21%), and triglycerides (≈14%-42%) in normal-weight, overweight, and obese humans. Whole-day fasting trials (12 to 24 weeks) reduced body weight (≈3%-9%) and body fat, while reducing total cholesterol by ≈5%-20% and triglycerides by ≈17%-50%. Research on time-restricted feeding was noted as limited, precluding clear conclusions.
Tinsley GM, La Bounty PM Nutr Rev, 2015. PMID 26374764
2015 / Editorial / narrative review
This editorial discusses the combined effects of routine exposure to artificial light at night (ALAN) and daytime sunlight underexposure. ALAN is linked to increased risks of breast and prostate cancer through melatonin suppression, circadian desynchronization, and sleep disruption. Concurrently, inadequate daytime UV-B exposure leads to widespread vitamin D deficiency. The authors note that prior epidemiological studies have focused separately on too little UV-B or too much ALAN, and argue that research into the combined consequences of suppressed vitamin D and melatonin synthesis is needed.
Shows an association, not proof of cause and effect.
Smolensky MH, Sackett-Lundeen LL, Portaluppi F Chronobiol Int, 2015. PMID 26374931
2015 / Narrative review
This review summarizes evidence on the functional role of palm oil and its primary saturated fatty acid, palmitic acid, in human health and nutrition. It addresses controversial studies linking high palmitic acid content to potential adverse effects. The article specifically evaluates their involvement in obesity, type 2 diabetes mellitus, cardiovascular diseases, and cancer, alongside the atherogenic potential and stereospecific position of palmitic acid in triacylglycerols.
Mancini A, Imperlini E, Nigro E, et al. Molecules, 2015. PMID 26393565
2015 / Narrative review
This review examines literature regarding the adverse effects of primary sleep deficiency and deprivation on the cardiovascular system. Decreased sleep quantity and quality have been associated with cardiovascular disease risk factors, including hypertension, obesity, diabetes, and dyslipidemia. The authors cite endothelial dysfunction as a common underlying mechanism connecting sleep deficiency to cardiovascular disease.
Shows an association, not proof of cause and effect.
Kohansieh M, Makaryus AN Int J Hypertens, 2015. PMID 26495139
2015 / Narrative review
This review examines the optimal use of plant stanol ester in the dietary management of hypercholesterolemia. Safety and efficacy have been confirmed in over 70 published clinical studies, with a daily intake of 2 g plant stanols as plant stanol ester lowering LDL-cholesterol by 10% on average. For optimal cholesterol lowering, the review notes plant stanol ester should be used daily, in sufficient amounts, with a meal, and alongside other recommended dietary changes.
Rosin S, Ojansivu I, Kopu A, et al. Cholesterol, 2015. PMID 26543642
2015 / Narrative review
This narrative review evaluates cardiovascular diseases through an evolutionary biology perspective. Ancestral exposure to infections and starvation selected for proinflammatory genes, fat accumulation via a thrifty genotype, and insulin resistance to sustain gluconeogenesis. Today, obesity promotes a proinflammatory state through adipokine secretion, contributing to cardiometabolic disease, atherosclerosis, and diabetes. The abstract suggests that if an ancestral lifestyle of increased exercise and calorie restriction could be recovered, obesity, chronic low-grade inflammation, atherosclerosis, and diabetes could theoretically be reduced.
Rubio-Ruiz ME, Peredo-Escárcega AE, Cano-Martínez A, et al. Int J Evol Biol, 2015. PMID 26693381
2015 / Clinical practice guideline / expert consensus
An expert panel convened by the National Lipid Association developed recommendations for patient-centered management of dyslipidemia, guided by the principle that lowering atherogenic cholesterol reduces atherosclerotic cardiovascular disease risk. This document (Part 2) focuses on lifestyle therapies, management in special populations (such as youth, women, older patients, specific ethnic groups, and those with HIV or rheumatoid arthritis), and strategies to enhance adherence through team-based collaborative care.
Jacobson TA, Maki KC, Orringer CE, et al. J Clin Lipidol, 2015. PMID 26699442
2015 / Narrative review
This narrative review examines the relationship between obesity, insulin resistance, and cancer. Globally, overweight and obese individuals increased from just over 500 million in 2008 to 1.9 billion in 2014, with at least 2.8 million related deaths occurring each year. The authors note that expansion of adipose tissue leads to insulin resistance and hyperinsulinemia, which provide a clear link between obesity and the etiology of type 2 diabetes and cancer.
Shows an association, not proof of cause and effect.
Poloz Y, Stambolic V Cell Death Dis, 2015. PMID 26720346
2014 / Narrative review of epidemiological studies
This review summarizes evidence from epidemiological studies on the most probable adverse health effects of regular cannabis use sustained over years. The evaluation focused on outcomes with established associations, controlled alternative explanations, ruled-out reverse causation, and biological plausibility. The most probable adverse outcomes identified include a dependence syndrome, impaired respiratory function, cardiovascular disease, adverse effects on adolescent psychosocial development and mental health, and residual cognitive impairment.
Shows an association, not proof of cause and effect.
Hall W, Degenhardt L Drug Test Anal, 2014. PMID 23836598
2014 / Review
A review examined the effects of vegetarian diets on non-communicable diseases. Mortality from all-cause, ischemic heart disease, and circulatory and cerebrovascular diseases was significantly lower in vegetarians compared with omnivorous populations. The incidence of cancer and type 2 diabetes was also significantly lower in vegetarians. However, vegetarians presented increased risk factors including higher plasma homocysteine, mean platelet volume, and platelet aggregability, which were associated with low intakes of vitamin B12 and n-3 polyunsaturated fatty acids.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Li D J Sci Food Agric, 2014. PMID 23965907
2014 / Narrative review
This review examined the potential role of dark chocolate and cocoa polyphenols in managing obesity. Evidence from animal models, cell cultures, and a small number of human observational and clinical trials indicates promising effects. Suggested mechanisms include decreasing the expression of genes involved in fatty acid synthesis, reducing the digestion and absorption of fats and carbohydrates, and increasing satiety.
Farhat G, Drummond S, Fyfe L, et al. Phytother Res, 2014. PMID 24000103
2014 / Narrative review
This review examines population-wide dietary salt reduction to reduce the burden of hypertension in Nigeria. Hypertension prevalence in Nigeria has increased from 11% two decades ago to approximately 30% in recent times. The authors explore evidence for salt reduction strategies, review methods used in other countries, and provide recommendations for implementation in the Nigerian context.
Mezue K Perspect Public Health, 2014. PMID 24002906
2014 / Literature review
This review examined studies from CINAHL, Medline, Health Source, and the Cochrane Library to assess statin effects on plasma CoQ10 and the impact of CoQ10 supplementation on statin-related myopathy. Reviewed studies indicated a significant relationship between statin intake and decreased serum CoQ10 levels. A few studies reported benefits in myalgia symptoms or improved serum CoQ10 levels with supplementation at doses between 30 and 200 mg daily, though one study found no benefit. No adverse risks of supplementation were reported across the studies.
Littlefield N, Beckstrand RL, Luthy KE J Am Assoc Nurse Pract, 2014. PMID 24170646
2014 / Narrative review
This review evaluates the known cardiovascular, cerebrovascular, and peripheral effects of marijuana inhalation. Temporal associations between marijuana use and severe events—such as myocardial infarction, sudden cardiac death, cardiomyopathy, stroke, transient ischemic attack, and cannabis arteritis—have been described. The authors highlight the need for intensified safety research and increased clinical awareness.
Shows an association, not proof of cause and effect.
Thomas G, Kloner RA, Rezkalla S Am J Cardiol, 2014. PMID 24176069
2014 / Narrative review
Recent studies suggest a potential role for intestinal microbes in the expression of certain human cardio-metabolic diseases. Mechanisms through which gut microbiota and their metabolic products affect systemic homeostasis and cardio-metabolic risks are beginning to be uncovered. Human intervention studies focused on altering microbial composition or pharmacologically manipulating microbiota to influence metabolite production are needed next steps.
Vinjé S, Stroes E, Nieuwdorp M, et al. Eur Heart J, 2014. PMID 24216389
2014 / Narrative review
This paper reviews animal and human studies investigating the glucose- and lipid-lowering effects of various commonly consumed legumes. The authors conclude that various legumes possess varying degrees of antidiabetic potential. Additionally, legumes are reported to be beneficial in decreasing risk factors for cardiovascular and renal disease.
Singhal P, Kaushik G, Mathur P Crit Rev Food Sci Nutr, 2014. PMID 24261538